¥1,353.00
1.58%
Tokyo, Sep 25, 02:35 pm JST. Closed.
ISIN
JP3379950003
Symbol
2395

Shin Nippon Biomedical Laboratories,ltd. Stock price

¥1,352.00
-34.00 2.45% 1M
-128.00 8.65% 6M
-320.00 19.14% YTD
-393.00 22.52% 1Y
-609.00 31.06% 3Y
+435.42 47.50% 5Y
+729.70 117.26% 10Y
-541.37 28.59% 20Y
Tokyo, Closing price Fri, Sep 25 2026
+20.00 1.50%

Is Shin Nippon Biomedical Laboratories,ltd. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,127 stocks worldwide.

Key metrics

Basic
Market capitalization
¥55.5b
Enterprise Value
¥78.7b
Net debt
¥23.2b
Cash
¥14.3b
Shares outstanding
41.6m
Valuation (TTM | estimate)
P/E
10.5
P/S
1.6 | 1.4
EV/Sales
2.3 | 2.0
EV/FCF
-
P/B
1.3
Dividends
DPS
¥50.00
Yield 1Y | 5Y
3.7% | 2.9%
Growth 1Y | 5Y
0.0% | 10.8%
Payout 1Y | 3Y
45.6% | 41.6%
Increased
0 Years
Financials (TTM | estimate)
Revenue
¥33.9b | ¥38.9b
EBITDA
-
EBIT
¥3.5b
Net Income
¥5.4b
Free Cash Flow
-
Growth (TTM | estimate)
Revenue
1.7% | 19.5%
EBITDA
-
EBIT
26.1%
Net Income
6.1%
Free Cash Flow
-
Margin
Gross
50.8%
EBITDA
-
EBIT
10.4%
Net
15.8%
Free Cash Flow
-
Financial Health
Equity Ratio
41.1%
Return on Equity
10.6%
ROCE
5.8%
ROIC
3.9%
Debt/Equity
0.9
More
EPS
¥129.0
FCF per Share
-
Short interest
-
Employees
2k
Rev per Employee
¥21.4m

Shin Nippon Biomedical Laboratories,ltd. Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a Shin Nippon Biomedical Laboratories,ltd. forecast:

4x Buy
67%
2x Hold
33%

Analyst Opinions

6 Analysts have issued a Shin Nippon Biomedical Laboratories,ltd. forecast:

Buy
67%
Hold
33%

Financial data from Shin Nippon Biomedical Laboratories,ltd.

Jun '26
+/-
%
33,916 33,916
2% 2%
100%
- Direct Costs 16,699 16,699
2% 2%
49%
17,217 17,217
1% 1%
51%
- Selling and Administrative Expenses 13,701 13,701
4% 4%
40%
- Research and Development Expense - -
-
-
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 3,517 3,517
26% 26%
10%
Net Profit 5,370 5,370
6% 6%
16%

In millions JPY.

Don't miss a Thing! We will send you all news about Shin Nippon Biomedical Laboratories,ltd. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Shin Nippon Biomedical Laboratories, Ltd. is a contract research organization providing drug development services including safety research, clinical pharmacology, and clinical trials. The company is headquartered in Chuo-Ku, Tokyo-To and currently employs 1,436 full-time employees. The company went IPO on 2004-03-08. The company operates through four business segments. CRO segment includes non-clinical business using laboratory animals, cells, and bacteria to confirm the efficacy and safety of drugs under development by pharmaceutical companies, and clinical business, conducting trials to confirm efficacy and safety in humans. Translational Research segment develops nasal delivery platform technologies and conducts non-clinical and clinical testing necessary for the evaluation and approval of pharmaceuticals and others. Medipolis segment operates accommodation facilities and geothermal power generation businesses. United States Real Estate segment rents out multi-purpose industrial buildings constructed on sites owned by its subsidiary. The company also undertakes administrative work and provides support for the group's operations.

Head office Japan
CEO Mr. Nagata
Employees 1,522
Website snbl.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today